Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR2 | O95136 | 10/20 | 0.62 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23909034 | 0.87 | S1PR2 (0.81) | S1PR2AKR1B1CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL23908760 | 0.86 | S1PR2 (0.67) | S1PR2POLBATMCYP1A2CYP3A4 | |
| SCHEMBL23966880 | 0.83 | S1PR2 (0.67) | S1PR2AKR1B1POLBATMMAPT | |
| SCHEMBL23914842 | 0.83 | S1PR2 (0.65) | S1PR2POLBATMCYP1A2CYP3A4 | |
| SCHEMBL23915576 | 0.82 | S1PR2 (0.67) | S1PR2AKR1B1CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL23909018 | 0.80 | S1PR2 (0.84) | S1PR2MAPT | |
| SCHEMBL23908866 | 0.78 | S1PR2 (0.68) | S1PR2AKR1B1POLBATMMAPT | |
| SCHEMBL23908998 | 0.77 | S1PR2 (0.83) | S1PR2AKR1B1 | |
| SCHEMBL23908951 | 0.77 | S1PR2 (1.00) | S1PR2CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL23908799 | 0.77 | S1PR2 (0.80) | S1PR2AKR1B1CYP1A2CYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3649119-B1 | NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS | GALAPAGOS NV (BE) | 2021-11-03 | — | — | EP | disclosed |